Question Two: What are the expression patterns of different alternative HNF1A-AS1 transcripts at different conditions, including during cell growth and development, after exposure to xenobiotics (such as drugs), and in liver disease conditions (such as MASLD, ALD cirrhosis, and obesity liver)? Here, HNF1A is linked to metabolic dysfunction-associated steatotic liver disease.